FGF21 and liver disorder: To this end, and taking advantage of recent advancements in CRISPR/Cas9 technology, we capitalised on the translational value of rat models of liver disease and addiction to develop a novel, FGF21 knockout rat and determine its suitability as a genetic, physiological model for human MASH and alcohol-use disorder.